Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03408561

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

The Use of Social Media Listening for Targeted Recruitment of Twitter Users in LA County in Cancer Trials Compared to Historic Recruitment Data: A Mixed-Methods Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies how well social media listening works in improving clinical trial recruitment in patients with cancer. Social media listening and recruitment on Twitter may enhance enrollment for cancer-related clinical trials.

Detailed description

PRIMARY OBJECTIVES: I. Examine the feasibility (acceptance among University of Southern California \[USC\] Norris study team members and Twitter users in Los Angeles \[LA\] county) of targeted social media listening (SML) via Twitter as a tool for enhancing recruitment to cancer trials. II. Gain preliminary data on the impact (i.e., numbers recruited versus projected accrual compared to historic recruitment) of targeted social media listening (SML) as a tool for enhancing recruitment to cancer trials among Twitter users in LA county. III. Estimate the effect size of the number of people enrolled associated with the use of targeted social media listening (SML) via Twitter as a tool for enhancing recruitment to cancer trials. OUTLINE: Patients who mention specific cancer disease keywords and/or hashtags are identified and receive a message via Twitter. Patients are then contacted for recruitment into a clinical trial.

Conditions

Interventions

TypeNameDescription
OTHERInternet-Based InterventionReceive message via Twitter
OTHERSurvey AdministrationAncillary studies

Timeline

Start date
2017-11-08
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2018-01-24
Last updated
2019-09-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03408561. Inclusion in this directory is not an endorsement.